ANRO — Alto Neuroscience, Inc. catalysts
Next verified catalyst
2026-08-01 — ALTO-100 in Bipolar Disorder With Depression (BD-D) · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08 (month) in 1mo
ESTIMATED |
READOUT
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Phase 2 · Bipolar Disorder I or II With a Major Depressive Episode |
ANRO Alto Neuroscience, Inc. | ALTO-100 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|